Clinical Trials

70 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05626101 2024-02-13

Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study

280 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06245759 2024-02-07

The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients

120,000 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05176145 2023-10-13

DMIA

400 enrolled

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT05975151 2023-09-21

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Phase 2 Unknown

63 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Pseudomonas Infections

NCT04943094 2023-05-31

URODYN

50 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05084586 2023-03-28

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

100 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence

NCT05508568 2023-02-01

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

650 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05704231 2023-01-30

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

60 enrolled

Non-Muscle Invasive Bladder Neoplasms, Recurrence, Smoking, Disease Progression

NCT05580354 2022-10-14

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Phase 4 Unknown

42 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05547516 2022-09-21

BL-PDT-RCT

140 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05464576 2022-09-02

IRMAA

150 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Disease

NCT04839029 2022-07-19

Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT

200 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05332353 2022-04-18

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

100 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04617743 2022-04-12

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

500 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT04819399 2022-04-05

Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC

30 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04490993 2022-02-22

ACCRUE

Phase 3 Unknown

359 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

Phase 3 Unknown

800 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03421236 2021-04-28

Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

25 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04859751 2021-04-26

Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Phase 3 Unknown

53 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04644835 2020-12-21

Low Energy Shock Wave Therapy and Non-Muscle Invasive Bladder Cancer

50 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04664816 2020-12-21

Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer

110 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03560479 2020-08-19

A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer

Phase 1/2 Unknown

52 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms

NCT03950362 2019-05-16

PREVERT

Phase 2 Unknown

67 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03914001 2019-04-12

Comprehensive Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Non Muscle-invasive Bladder Tumor; Can it Replace Second Look Biopsy? A Prospective Study

100 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03148158 2018-01-09

Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident

300 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Disease, Pain, Postoperative

NCT03221062 2017-07-21

"En Bloc" Resection of NMIBC: a Prospective， Single Centre，Randomized Study

Phase 4 Unknown

180 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03038321 2017-05-23

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Phase 4 Unknown

150 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis

NCT03121768 2017-05-16

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

761 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Recurrence, Disease Progression

NCT02075060 2017-04-06

IPOI vs IPOP

Phase 2 Unknown

54 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT02895620 2016-09-09

CEPHEID

24 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT00959868 2012-02-13

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

36 enrolled

Neuronopathy, Distal Hereditary Motor, Type IIB, Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00816075 2009-02-17

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

Phase 2/3 Unknown

40 enrolled

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT00109655 2008-10-03

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

75 enrolled